SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-03-036312
Filing Date
2003-08-14
Accepted
2003-08-13 18:21:55
Documents
7
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT d10q.htm 10-Q 319211
3 GENERAL RELEASE AND SETTLEMENT AGREEMENT dex101112.htm EX-10.11.12 26476
4 EMPLOYMENT AGREEMENT dex1094.htm EX-10.94 38848
5 CONTRACT DEVELOPMENT AND MANUFACTURING AGREEEMENT dex1095.htm EX-10.95 54434
6 CERTIFICATION ON PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 7372
7 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 7352
8 CERTIFICATION UNDER SECTION 906 OF THE SARBANESE-OXLEY ACT OF 2002 dex32.htm EX-32 3648
  Complete submission text file 0001193125-03-036312.txt   459576
Mailing Address
Business Address 11011 VIA FRONTERA SAN DIEGO CA 92127 6194513771
SYNBIOTICS CORP (Filer) CIK: 0000719483 (see all company filings)

IRS No.: 953737816 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-11303 | Film No.: 03842847
SIC: 2835 In Vitro & In Vivo Diagnostic Substances